Heart failure linked to diversity of gut flora

c8fab857-50ce-4cc0-9f60-32c901e522b9articleimage.jpg

13 Jul 2017 --- New data obtained by scientists of the German Centre for Cardiovascular Research (DZHK) provide valuable points of departure for understanding how gut colonization is associated with the development and progress of heart failure. Notably, researchers have found that important groups of bacteria are found less frequently in the gut of patients with heart failure, and the gut flora is not as diverse as in healthy individuals. 

The link between heart failure and gut health is well known. The gut has a worse blood supply in instances of heart failure; the intestinal wall is thicker and more permeable, whereby bacteria and bacterial components may find their way into the blood. Moreover, scientists know that the composition of the gut bacteria is altered in other widespread diseases such as type 2 diabetes. Against this backdrop, researchers at the DZHK site Hamburg/Kiel/Lübeck investigated whether and how the gut flora in patients with heart failure changes.

In a project headed by Professor Norbert Frey of the University Hospital Schleswig-Holstein, Campus Kiel, researchers analyzed the gut bacteria in stool samples of healthy individuals and patients with heart failure. The study was conducted in close cooperation with Professor Andre Franke’s team at the Christian-Albrechts-Universität zu Kiel, which found that the sections of the bacterial genome deciphered the distinction of the microorganism. 

The results showed that a significantly lower proportion of different bacteria are found in the gut in patients with heart failure than in healthy controls. Individual important families of bacteria are significantly reduced. It is still unclear whether the gut flora is altered as a result of heart failure or whether it may be a trigger for this disease.

“Of course, other factors also affect the composition of our gut bacteria. We know that the gut flora of a vegan who starts eating meat changes within three days,” explains associate professor Dr. Mark Lüdde of the University Hospital Schleswig-Holstein, Campus Kiel. 

For this reason, individuals with an extreme diet, such as a vegan diet, were not allowed to participate in the study. Instead, they chose individuals with a standard diet comprising both meat and vegetables for both groups, according to Lüdde.

In addition to diet, medication also affects the gut flora. It was, therefore, important that the control group also took medicinal products that patients with heart failure must take routinely. Antibiotics could not have been administered for at least three months prior. Smokers were also included in both groups. All participants were from the same region and were the same age; gender distribution and BMI were equal in both groups.

The observed pattern of the reduced genera and families of bacteria seems very characteristic of heart failure, which is why these results may be new points of departure for therapies. The differences between healthy individuals and those with heart failure, thus, came about mainly through the loss of bacteria of the genera Blautia and Collinsella, as well as two previously unknown genera that belong to the families Erysipelotrichaceae and Ruminococcaceae

Other research projects have shown that the occurrence of Blautia curbs inflammations. Similarly, the genus Faecalibacterium is associated with anti-inflammatory mechanisms. It is, however, not only reduced in patients with heart failure. Since heart failure is accompanied by chronic inflammation, one theory is that the gut flora fosters the systemic inflammation. Scientists currently believe that the gut flora changes as a consequence of heart failure. 

Lüdde and his colleagues believe it is plausible that an altered bacterial profile could also be a risk factor or an early disease marker for heart failure. This is supported by the recent characterization of trimethylamine N-oxide (TMAO), a metabolic product of gut bacteria, as an independent risk factor for the mortality rate in patients with heart failure. 

Related Articles

Nutrition & Health News

Yogurt may reduce cardiovascular disease risk

19 Feb 2018 --- A higher yogurt intake is associated with lower cardiovascular disease risk among hypertensive men and women, a study in the American Journal of Hypertension suggests. High blood pressure is a major cardiovascular disease risk factor. Clinical trials have previously demonstrated beneficial effects of dairy consumption on cardiovascular health, and yogurt may independently be related to cardiovascular disease risk.

Nutrition & Health News

Immunity boosters (Part 2): Not diplomatic about immunity – Innovation, new ingredients and R&D

12 Feb 2018 --- Immune health continues to drive trends in the nutrition industry. Today, in the second part of a special report, NutritionInsight continues its in-depth look at the latest ideas in the industry in the immune health space.

Nutrition & Health News

Cognitive health: High-salt diet linked to dementia, finds mouse study

17 Jan 2018 --- Excessive consumption of salt is known to affect heart health and blood pressure, but research by scientists at Weill Cornell Medicine has now underlined its negative effect on cognitive health. According to their study, a high-salt diet reduces resting blood flow to the brain and causes dementia in mice. The study, published on Monday in Nature Neuroscience, is the first to unveil a gut-brain connection linking high dietary salt intake to neurovascular and cognitive impairment. The findings illuminate a potential future target for countering harmful effects to the brain caused by excess salt consumption.

Nutrition & Health News

Activity trackers only effective when users set defined goals

09 Jan 2018 --- Although activity monitors can have a significant impact when users establish defined objectives, the trackers that many received as holiday gifts will not automatically make their recipients active or healthy, new research indicates.

Nutrition & Health News

DSM expands gut health ingredients portfolio with acquisition of BioCare Copenhagen

02 Jan 2018 --- Royal DSM has acquired BioCare Copenhagen A/S to expand its offering in gut health ingredients with probiotics, an attractive market segment in nutritional ingredients, growing an estimated 7 percent per year. Financial details will not be disclosed at this time.

More Articles
URL : http://www.nutritioninsight.com:80/news/heart-failure-linked-to-diversity-of-gut-flora.html